hypoactive sexual desire dysfunction
Women's health · 2025–2025
1decision
1medicine
1carried consumer input
368individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| testosterone Treatment of hypoactive sexual desire dysfunction (HSDD) in postmenopausal women who have failed appropriate education and correction of modifiable… | Nov 2025 | Not recommended | 368 individuals Australasian Menopause Society · Research Institute · Genspect Australia · GB Alliance Australia |
Who spoke
Australasian Menopause Society · Research Institute · Genspect Australia · GB Alliance Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.